Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer.

Clinical lung cancer - 1 Nov 2025

Deek Rebecca A, Kim Jongmyung, Kumar Ritesh, Medina Benjamin, Langenfeld John, Kontopidis Ioannis, Lazzaro Richard, Nie Ke, Hathout Lara, Guler Ozan, Onal Cem, Patel Eshan, Haigentz Missak, Jabbour Salma K, Deek Matthew P

Abstract excerpt

INTRODUCTION: Treatment of metastatic disease is rapidly evolving with local therapies increasingly being used in patients with oligometastasis. Better personalization is needed to appropriate select patients for these interventions. We attempted to better understand clinical features and genomic features of oligometastatic nonsmall cell lung cancer (NSCLC). MATERIALS AND METHODS: Patients with metastatic NSCLC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Neoplasm Metastasis

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 40897601
DOI: 10.1016/j.cllc.2025.07.010
PMCID: PMC13080795

Genes

ALK
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer.PMID 40897601Read ↗

Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.Semantic proximity Read ↗

Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases.Semantic proximity Read ↗

Prognostic and Predictive Biomarkers in Oligometastatic Disease.Semantic proximity Read ↗

Genomic features and its potential implication in bone oligometastatic NSCLC.Semantic proximity Read ↗

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.Semantic proximity Read ↗

Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.Semantic proximity Read ↗

(Oligo)metastasis as a Spectrum of DiseaseSemantic proximity Read ↗

Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New PerspectivesSemantic proximity Read ↗

Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.